Toward the Realization of a Decarbonized Society
Climate change is an unavoidable and urgent issue for all humanity. The effects of rising average temperatures, damage caused by heavy rains and typhoons, and their impact on crops and ecosystems have already been observed worldwide. It is thought that continued greenhouse gas emissions in the future will have even more serious effects on nature and human society.
The Nichiban Group positions climate change and global warming countermeasures, product development that resolves environmental and social issues, and the reduction of environmental impacts through business activities as its materiality (key issues), and will promote efforts to respond to climate change and contribute to a decarbonized society.
CO2 Emissions Reductions
In the Corporate Governance Report disclosed on June 29, 2022, we announced Scope 1 and 2 CO2 emission reduction targets as one of the critical environmental and social issues that must be addressed, calling for a 40% reduction in CO2 in 2030 and a 100% reduction in 2050 compared to fiscal 2013. To this end, in fiscal 2022, research and production began working together to develop new products based on environmentally friendly manufacturing methods. In addition to energy conservation and yield improvement efforts we have been engaged in for some time, we will strive to develop new products with low environmental impact in order to achieve these targets.
- FY2030 Reduce CO2 emissions in Scope 1 and 2 by 40%(compared with FY2013)
FY2050 Reduce CO2 emissions in Scope 1 and 2 by 100%(compared with FY2013) - Increase the rate of renewable energy and improve production efficiency to achieve the reduction target.
Renewable Energy Initiatives
To reduce CO2 emissions through energy reductions, Nichiban Medical Corp. completed the installation of solar panels on the roof of its factory in October 2020 and September 2022. As a result, the amount of electricity generated in fiscal 2022 amounted to 494,000 kWh.
NBM Solar Power Generation FY2022 Results | 494,000 kWh |
---|
Green Power
Nichiban purchases Green Power Certificates from Japan Natural Energy Co., Ltd., for the electricity it uses with the aim of converting 100% of the electricity used by the Nichiban Group and affiliated companies in the production of cellulose tape and cellophane-based adhesive tape, the electricity used at the Headquarters and seven sales offices nationwide, and the electricity used in the manufacture of CARELEAVES™ produced by Nichiban Medical to green power.
Contracted volume in FY2021 | 9,250,000 kWh |
---|---|
Contracted volume in FY2022 | 11,100,000 kWh |
Contracted volume in FY2023 (forecast) | 11,500,000 kWh |